PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia
暂无分享，去创建一个
Logan A. Walker | J. Byrd | R. Bundschuh | G. Behbehani | M. Phelps | X. Mo | P. Yan | N. Muthusamy | Chi-Ling Chiang | A. Walker | Min Chen | Zhiliang Xie | S. Goswami | R. Mani | Chad E. Bennett | A. Mims | R. Lapalombella | N. Grieselhuber | Larry P. Beaver | Eileen Y. Hu | S. Vasu | R. Devine | F. Frissora | Y. Tsai | K. Larkin | J. Nunes | K. Zapolnik | Ann Ventura | E. Hertlein